Example: Heart Attack
Clinical Trials on Congenital Insensitivity to Pain
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome
- Coagulopathy During Cardiac Surgery
- Congenital Syphilis
- Coronaviridae Infections
- Environmental Contamination
- Intra-Abdominal Hypertension
- Large B-cell Diffuse Lymphoma of Testis
- Non-FL Indolent Non-Hodgkin's Lymphoma
- Parenting Education Curriculum
- Pellucid Marginal Corneal Degeneration
- Refractory T-Cell Non-Hodgkin Lymphoma
- Stage IV Renal Cell Cancer AJCC v7
- for Substance Abuse Treatment
- View Full List
Sponsors and Collaborators
- Andrea Harzstark
- Arjohuntleigh
- Dicentra Inc.
- Dr Ivana Ricca
- Fasila Hemodialysis Center
- GeneOne Life Science, Inc.
- Kløveråsen, Bodø
- Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen
- Ospedali dei Colli
- Teva Pharmaceutical Industries, Ltd.
- The Second Affiliated Hospital of University of South China
- Tongue Laboratory
- USC Spine, Keck hospital of USC, Los Angeles, CA, USA
- View Full List
Drug Interventions
- 1000 mg metformin
- Comparator : atenolol /Duration of Treatment : 16 Weeks
- Fenoldopam
- NYC 0462 Ointment
- Pegylated Interferon Alfa 2a
- Quetiapine Fumarate Sustained Release
- Statin plus fenofibrate
- Suspension (10 ml) containing 100 mg of polymyxin B, 80 mg of gentamycin, 350 mg of amphotericine B and 500 mg of vancomycin q6h
- Testim®
- [11C]-CS1P1
- artemether- lumefantrine
- disopyramide
- huperzine 0.2 mg BID
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations